What are the risks of transplanting frozen ovarian tissue back into the patient?
- What is the current state of ovarian tissue cryopreservation research?
- What is the National Fertility Hotline and how is it useful to people with cancer and their families?
- How can I stay current on Oncofertility research?
- What are the basics of ovarian tissue cryopreservation at Northwestern?
- What does ovarian tissue cryopreservation offer that other procedures cannot?
The video What are the risks of transplanting frozen ovarian tissue back into the patient? requires the Adobe Flash Player. You can download the latest version of Flash here.
You can also read the transcript of the video below.
Ralph Kazer, M.D.
Professor, Ob/Gyn
Oncofertility Consortium
Feinberg School of Medicine, Northwestern University
With respect to the option of transplanting frozen ovarian tissue back into the patient from whom the tissue came in certain circumstances, in cases where the patient has certain types of cancer, it is considered unwise to do this because of the concern that microscopic focuses of the cancer may be present in the tissue and may in essence re-seed the patient’s body with the cancer of which they’ve been cured.
Two types of cancers which are of particular concern when the issue of reintroducing the cancer arise are cancers that the patient had involves her blood cell system or cancers that involve the ovary itself.
